Aldeyra Therapeutics Inc (NASDAQ:ALDX) shares, rose in value, with the stock price up by 0.16% to the previous day’s close as strong demand from buyers drove the stock to $6.31.
Actively observing the price movement in the recent trading, the stock is buoying the session at $6.30, falling within a range of $6.26 and $6.59. The value of beta (5-year monthly) is 1.235. Referring to stock’s 52-week performance, its high was $7.20, and the low was $2.88. On the whole, ALDX has fluctuated by -4.25% over the past month.
With the market capitalization of Aldeyra Therapeutics Inc currently standing at about $376.76 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-27.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach -800k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ALDX’s technical picture suggests that short-term indicators denote the stock is a 75% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of ALDX currently trading nearly -2.27% and 4.57% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.27, while the 7-day volatility ratio is showing 6.03% which for the 30-day chart, stands at 9.25%. Furthermore, Aldeyra Therapeutics Inc (ALDX)’s beta value is 0.91, and its average true range (ATR) is 0.45.
A comparison of Aldeyra Therapeutics Inc (ALDX) with its peers suggests the former has fared considerably weaker in the market. ALDX showed an intraday change of 0.16% in today’s session so far, and over the past year, it grew by 119.10%%.
Data on historical trading for Aldeyra Therapeutics Inc (NASDAQ:ALDX) indicates that the trading volumes over the past 10 days have averaged 0.69 and over the past 3 months, they’ve averaged 505.60K. According to company’s latest data on outstanding shares, there are 59.65 million shares outstanding.
Nearly 2.90% of Aldeyra Therapeutics Inc’s shares belong to company insiders and institutional investors own 62.59% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.99 million shares as on 2025-03-14, resulting in a short ratio of 6.27. According to the data, the short interest in Aldeyra Therapeutics Inc (ALDX) stood at 805.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.68 million. The stock has risen by 26.45% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALDX stock heading into the next quarter.
